Total Voting Rights

Summary by AI BETAClose X

As at 31 October 2026 AstraZeneca’s issued share capital with voting rights was 1,551,065,237 ordinary shares of US$0.25, with no shares held in treasury, so the total number of voting rights is 1,551,065,237; this figure should be used as the denominator for FCA Disclosure and Transparency Rules notification thresholds.

Disclaimer*

Companies

AstraZeneca (AZN)
UK 100

Latest directors dealings